Company / Income Tax
Sana Biotechnology, Inc. Income Tax History
FY2019-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$7.5M
FY2019
5-year range
-
FY2019-FY2019
Trend
-
vs FY2018
Sector context
#189 of 204
Health Care
What the data says
Among 204 Health Care companies, Sana Biotechnology, Inc. is in the top 7% for income tax.
Based on SEC 10-K filings.
-$8M in FY2019.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 204This company -$7.5M Sector average $118.7M
▼
-106.4% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$7.5M | - |
As of FY2019 · SEC 10-K · Updated Feb 28, 2026